Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. (b) On November 16, 2007, the employment of Richard D. Brounstein, Executive Vice President of Calypte Biomedical Corporation, was terminated.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.